[Altering lifestyle and treating obesity, preventing type 2 diabetes?].
Sauvanet
Jean-Pierre
JP
Policlinique de médecine interne, Hôpital Saint-Louis, Paris.
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D004038:Diet, Reducing; D005081:Exercise Therapy; D005387:Finland / Q000453:epidemiology; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008019:Life Style; D009765:Obesity / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D000077403:Orlistat; D011322:Primary Prevention / Q000379:methods*; D011446:Prospective Studies; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat